Member Info for roses

Ripley, that was a UT trade.

The price never went to that, but I’m sure you know that already.

Crustypete, your last post doesn’t surprise me at all, you have attempted to find a negative slant on every aspect of the company.

Even when you try to hide the start of your post with a positive, your true intention is evident by the end of the post.

Indeed, a very good indicator of his belief in scancell’s prospects.

This close to significant milestones and considering redmile has been content on not only holding the legal maximum stake but also extending the due dates, I can’t see them changing their strategy this close to the tuning points and breakthrough achievements that are coming to fruition.

I think there is a high chance that if the modi results are confirmed with more patients then the platform will be bought up by one of the larger pharmaceutical companies later this year.

I see the resident nutter is going to be full time today.

I was mistakenly referring to modi1

Our results are already 100% - 200% better than the current standard of care

Kashdog, it will be the latter

“ Presenting data showing vaccine specific T cell responses at AACR IO is an important validation of SCIB1 efficacy”

I did take that into consideration.

Also 100k is only around £9k , not really a large transaction?

The de rampers have been putting in overtime for the last couple of weeks, however,

It looks as if calculus has completed their sales now.

Adding up the large transactions recently with their holdings seems to tally and the large sales have stopped with them culminating a week or so ago.

Now they are done, we don’t have to deal with calculus, just the usual negative few posters who will say anything whether it’s based on fact or not.

Scinv has shown his true colours over the last few days, he will spout anything whether it has any factual basis or not.

As with any stock you should follow the money.

We have multiple big funds oversubscribing on one hand

And one small fund selling as they said they would due to redemption criteria, the market makers know this and are making the most of it.

It doesn’t surprise me at all that there are a few trying their best to lower the price to get a better entry price, after all that’s what they’re paid for..

Just a reclassification of an existing liability.

Agreed, he seems exactly the right person to deliver the shareholders expectations.

Will be a very interesting few months coming up.

AI generated crap, don’t know why you keep posting from that site ?

I don’t know why all the doom and gloom, I’m taking full advantage of the low price and loading up.

Drac, nowhere near as bad as your ‘other’ stock

What is with these new posters that have started posting this week with accounts that have been dormant for years ?

You guys just keep moving on to the next one

I was told once by a wise old fecunder that these accounts were set up in the hundreds by CFD traders and unofficial market makers accounts to pounce on aim stocks when they think they can change sentiment tomake a quick buck.

You can smell them a mile off and as soon as they’re found out, the next one that was registered 4 plus years ago with no posts shows up.

AIM is rife with it.

Drac, indeed, the company has already said they have massively improved on the current standard of care albeit on low but increasingly higher numbers.

If the preclinical results translate into actual results as indicated then this will be a game changing market leader.

Interesting to see the company letting more people know about tomorrows updates.

Haven’t seen them do that before ???